Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and Related Disorders: Proof of Concept Study

NCT04978428 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04978428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04978428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and Related Disorders: Proof of Concept Study
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Completed
Start date
April 14, 2022
Completion date
November 1, 2025
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hoarding disorder, obsessive-compulsive disorder, tourette syndrome, trichotillomania (hair-pulling disorder)